RxDoctor Payments Data

Tonya Kaltenbach, MD

Gastroenterology · Palo Alto, CANPI 1578618419

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $181,286 of the $268,868 with a category attached, or 67.4%. Olympus Corporation accounts for 61.5% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $121,172, 2.8 times the $43,633 reported in 2019. Among gastroenterology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$268,868in general payments, 2019–2025

Across 234 payments — averaging $1149.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus Corporation$165K
  • Olympus Corporation Of The Americas$56K
  • Boston Scientific$30K
  • Olympus America Inc.$10K
  • Medtronic$5K
  • Olympus Medical Systems Corporation$3K
  • plus $750 from 1 others
$42,580in research payments, 2019–2025

Across 3 payments — averaging $14,193 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gyrus ACMI, Inc.$38K
  • Covidien LP$5K

What the payments were for

  • Consulting fees$181,28667%
  • Speaking & faculty fees$19,7667%
  • Travel & lodging$49,38918%
  • Food & beverage$3,6671%
  • Education$14,7605%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$268,868 in reported general payments places this provider in the 95th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California →

Medicare billing

Part B allowed, 2024
$20,669
Medicare patients
57
Services billed
99

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Palo Alto

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →